Cryo-Cell International
CCEL
12 hedge funds and large institutions have $1.77M invested in Cryo-Cell International in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
290% more capital inflows, than outflows
Capital inflows: $107K | Capital outflows: $27.6K
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
0.28% more ownership
Funds ownership: 6.61% → 6.89% (+0.28%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$71.2K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.4K |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$12.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.46K |
| 5 |
Barclays
London,
United Kingdom
|
+$50 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$25.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.27K |
| 3 |
SignatureFD
Atlanta,
Georgia
|
-$355 |
CCEL Hedge Fund Activity: Q2 2026 in Review
12 of the 8,365 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q2 2026, worth a combined $1.77M — down 6.4% from $1.89M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CCEL positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $71.2K. The largest seller was BlackRock, cutting an estimated $25.9K.
- 12 institutional investors held Cryo-Cell International (CCEL) as of Q2 2026, up from 11 in Q1 2026.
- Funds reported $1.77M of Cryo-Cell International stock for Q2 2026, down 6.4% quarter-over-quarter.
- 2 funds opened new Cryo-Cell International positions in Q2 2026 and 1 closed out, a net change of +1 holder.
- The largest Cryo-Cell International buyer in Q2 2026 was Fidelity Investments, an estimated $71.2K added.
- The largest Cryo-Cell International seller in Q2 2026 was BlackRock, an estimated $25.9K sold.
Based on aggregated 13F filings for Q2 2026.